nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—breast cancer—Conjugated Estrogens—osteoporosis	0.141	0.363	CpDpCtD
Testosterone Propionate—breast cancer—Estradiol—osteoporosis	0.141	0.363	CpDpCtD
Testosterone Propionate—breast cancer—Ethinyl Estradiol—osteoporosis	0.107	0.275	CpDpCtD
Testosterone Propionate—COMT—Conjugated Estrogens—osteoporosis	0.0951	0.392	CbGbCtD
Testosterone Propionate—AR—Ergocalciferol—osteoporosis	0.0773	0.319	CbGbCtD
Testosterone Propionate—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.0531	0.185	CrCrCtD
Testosterone Propionate—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.0519	0.181	CrCrCtD
Testosterone Propionate—AR—Estradiol—osteoporosis	0.0401	0.165	CbGbCtD
Testosterone Propionate—Formestane—Estropipate—osteoporosis	0.0391	0.137	CrCrCtD
Testosterone Propionate—Drostanolone—Estradiol—osteoporosis	0.0305	0.107	CrCrCtD
Testosterone Propionate—UGT1A1—Estradiol—osteoporosis	0.03	0.124	CbGbCtD
Testosterone Propionate—Formestane—Conjugated Estrogens—osteoporosis	0.0297	0.104	CrCrCtD
Testosterone Propionate—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.0206	0.072	CrCrCtD
Testosterone Propionate—Danazol—Ethinyl Estradiol—osteoporosis	0.019	0.0665	CrCrCtD
Testosterone Propionate—Norethindrone—Ethinyl Estradiol—osteoporosis	0.0166	0.0578	CrCrCtD
Testosterone Propionate—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.0136	0.0474	CrCrCtD
Testosterone Propionate—Testosterone—Estradiol—osteoporosis	0.0124	0.0433	CrCrCtD
Testosterone Propionate—CYP17A1—Endogenous sterols—CYP27A1—osteoporosis	0.000825	0.0609	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—SHBG—osteoporosis	0.00072	0.0532	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Glucocorticoid biosynthesis—POMC—osteoporosis	0.000606	0.0447	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Androgen biosynthesis—POMC—osteoporosis	0.00047	0.0347	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Endogenous sterols—CYP19A1—osteoporosis	0.000433	0.032	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000383	0.0283	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000378	0.0279	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—GSN—osteoporosis	0.000373	0.0276	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.000325	0.024	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00031	0.0229	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PARK7—osteoporosis	0.000276	0.0204	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Endogenous sterols—POMC—osteoporosis	0.00026	0.0192	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—BGLAP—osteoporosis	0.000237	0.0175	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—ESR2—osteoporosis	0.000225	0.0166	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000201	0.0149	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000199	0.0147	CbGpPWpGaD
Testosterone Propionate—Drostanolone—SHBG—osteoporosis	0.000196	0.0766	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000195	0.0144	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—VDR—osteoporosis	0.000178	0.0132	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000178	0.0131	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000177	0.0131	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP27A1—osteoporosis	0.000172	0.0127	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP27A1—osteoporosis	0.00017	0.0125	CbGpPWpGaD
Testosterone Propionate—Nandrolone phenpropionate—CYP19A1—osteoporosis	0.000169	0.0662	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—DKK1—osteoporosis	0.000169	0.0124	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP27A1—osteoporosis	0.000165	0.0122	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000163	0.012	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000163	0.012	CbGpPWpGaD
Testosterone Propionate—Testolactone—CYP19A1—osteoporosis	0.000161	0.0631	CrCbGaD
Testosterone Propionate—Ethynodiol—ESR1—osteoporosis	0.00015	0.059	CrCbGaD
Testosterone Propionate—Drostanolone—CYP19A1—osteoporosis	0.000144	0.0563	CrCbGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000141	0.0104	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—ESR1—osteoporosis	0.000136	0.0101	CbGpPWpGaD
Testosterone Propionate—Nandrolone decanoate—CYP19A1—osteoporosis	0.000128	0.0501	CrCbGaD
Testosterone Propionate—Norgestimate—ESR1—osteoporosis	0.000128	0.0501	CrCbGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—ESR1—osteoporosis	0.000121	0.00895	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000121	0.00893	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—SHBG—osteoporosis	0.000116	0.0454	CrCbGaD
Testosterone Propionate—Fluoxymesterone—SHBG—osteoporosis	0.000111	0.0433	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00011	0.00814	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000108	0.00795	CbGpPWpGaD
Testosterone Propionate—Danazol—SHBG—osteoporosis	0.000106	0.0414	CrCbGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000105	0.00774	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000105	0.00773	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000105	0.00772	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP27A1—osteoporosis	0.000103	0.00762	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000102	0.00751	CbGpPWpGaD
Testosterone Propionate—Spironolactone—SHBG—osteoporosis	0.000101	0.0397	CrCbGaD
Testosterone Propionate—Gastrointestinal pain—Estropipate—osteoporosis	0.0001	0.00149	CcSEcCtD
Testosterone Propionate—Mental disorder—Conjugated Estrogens—osteoporosis	9.99e-05	0.00148	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Alendronate—osteoporosis	9.95e-05	0.00148	CcSEcCtD
Testosterone Propionate—Oedema—Ethinyl Estradiol—osteoporosis	9.94e-05	0.00148	CcSEcCtD
Testosterone Propionate—Malnutrition—Conjugated Estrogens—osteoporosis	9.92e-05	0.00147	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Alendronate—osteoporosis	9.87e-05	0.00147	CcSEcCtD
Testosterone Propionate—Pain—Calcitriol—osteoporosis	9.84e-05	0.00146	CcSEcCtD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.8e-05	0.00724	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Ethinyl Estradiol—osteoporosis	9.74e-05	0.00145	CcSEcCtD
Testosterone Propionate—Hypertension—Pamidronate—osteoporosis	9.74e-05	0.00145	CcSEcCtD
Testosterone Propionate—Urticaria—Estropipate—osteoporosis	9.74e-05	0.00145	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	9.74e-05	0.00719	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Raloxifene—osteoporosis	9.71e-05	0.00144	CcSEcCtD
Testosterone Propionate—Diarrhoea—Etidronic acid—osteoporosis	9.69e-05	0.00144	CcSEcCtD
Testosterone Propionate—Haematuria—Estradiol—osteoporosis	9.69e-05	0.00144	CcSEcCtD
Testosterone Propionate—Abdominal pain—Estropipate—osteoporosis	9.69e-05	0.00144	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Ibandronate—osteoporosis	9.69e-05	0.00144	CcSEcCtD
Testosterone Propionate—Skin disorder—Ethinyl Estradiol—osteoporosis	9.65e-05	0.00143	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Estradiol—osteoporosis	9.61e-05	0.00143	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Ibandronate—osteoporosis	9.61e-05	0.00143	CcSEcCtD
Testosterone Propionate—Myalgia—Pamidronate—osteoporosis	9.61e-05	0.00143	CcSEcCtD
Testosterone Propionate—Arthralgia—Pamidronate—osteoporosis	9.61e-05	0.00143	CcSEcCtD
Testosterone Propionate—Urticaria—Alendronate—osteoporosis	9.59e-05	0.00142	CcSEcCtD
Testosterone Propionate—Anxiety—Pamidronate—osteoporosis	9.57e-05	0.00142	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Zoledronate—osteoporosis	9.56e-05	0.00142	CcSEcCtD
Testosterone Propionate—Abdominal pain—Alendronate—osteoporosis	9.54e-05	0.00142	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Risedronate—osteoporosis	9.5e-05	0.00141	CcSEcCtD
Testosterone Propionate—Discomfort—Pamidronate—osteoporosis	9.49e-05	0.00141	CcSEcCtD
Testosterone Propionate—Medroxyprogesterone Acetate—SHBG—osteoporosis	9.48e-05	0.0372	CrCbGaD
Testosterone Propionate—Skin disorder—Risedronate—osteoporosis	9.41e-05	0.0014	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Calcitriol—osteoporosis	9.41e-05	0.0014	CcSEcCtD
Testosterone Propionate—Norethindrone—SHBG—osteoporosis	9.4e-05	0.0368	CrCbGaD
Testosterone Propionate—Abdominal pain—Raloxifene—osteoporosis	9.39e-05	0.00139	CcSEcCtD
Testosterone Propionate—Urticaria—Ibandronate—osteoporosis	9.34e-05	0.00139	CcSEcCtD
Testosterone Propionate—Malaise—Zoledronate—osteoporosis	9.29e-05	0.00138	CcSEcCtD
Testosterone Propionate—Abdominal pain—Ibandronate—osteoporosis	9.29e-05	0.00138	CcSEcCtD
Testosterone Propionate—Confusional state—Pamidronate—osteoporosis	9.29e-05	0.00138	CcSEcCtD
Testosterone Propionate—Oedema—Pamidronate—osteoporosis	9.21e-05	0.00137	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Pamidronate—osteoporosis	9.21e-05	0.00137	CcSEcCtD
Testosterone Propionate—Haemoglobin—Estradiol—osteoporosis	9.17e-05	0.00136	CcSEcCtD
Testosterone Propionate—Urticaria—Calcitriol—osteoporosis	9.14e-05	0.00136	CcSEcCtD
Testosterone Propionate—Haemorrhage—Estradiol—osteoporosis	9.12e-05	0.00135	CcSEcCtD
Testosterone Propionate—Abdominal pain—Calcitriol—osteoporosis	9.1e-05	0.00135	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP19A1—osteoporosis	9.05e-05	0.00668	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Estropipate—osteoporosis	9.03e-05	0.00134	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Pamidronate—osteoporosis	9.03e-05	0.00134	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Estradiol—osteoporosis	9.01e-05	0.00134	CcSEcCtD
Testosterone Propionate—Vomiting—Etidronic acid—osteoporosis	9.01e-05	0.00134	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Estradiol—osteoporosis	8.97e-05	0.00133	CcSEcCtD
Testosterone Propionate—Urethral disorder—Estradiol—osteoporosis	8.94e-05	0.00133	CcSEcCtD
Testosterone Propionate—Rash—Etidronic acid—osteoporosis	8.93e-05	0.00133	CcSEcCtD
Testosterone Propionate—Dermatitis—Etidronic acid—osteoporosis	8.93e-05	0.00133	CcSEcCtD
Testosterone Propionate—Methyltestosterone—SHBG—osteoporosis	8.93e-05	0.035	CrCbGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP19A1—osteoporosis	8.92e-05	0.00659	CbGpPWpGaD
Testosterone Propionate—Hypertension—Zoledronate—osteoporosis	8.9e-05	0.00132	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Alendronate—osteoporosis	8.9e-05	0.00132	CcSEcCtD
Testosterone Propionate—Headache—Etidronic acid—osteoporosis	8.88e-05	0.00132	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Risedronate—osteoporosis	8.83e-05	0.00131	CcSEcCtD
Testosterone Propionate—Asthenia—Estropipate—osteoporosis	8.8e-05	0.00131	CcSEcCtD
Testosterone Propionate—Arthralgia—Zoledronate—osteoporosis	8.77e-05	0.0013	CcSEcCtD
Testosterone Propionate—Myalgia—Zoledronate—osteoporosis	8.77e-05	0.0013	CcSEcCtD
Testosterone Propionate—Insomnia—Risedronate—osteoporosis	8.76e-05	0.0013	CcSEcCtD
Testosterone Propionate—Anxiety—Zoledronate—osteoporosis	8.74e-05	0.0013	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	8.71e-05	0.00129	CcSEcCtD
Testosterone Propionate—Paraesthesia—Risedronate—osteoporosis	8.7e-05	0.00129	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	8.68e-05	0.00641	CbGpPWpGaD
Testosterone Propionate—Pruritus—Estropipate—osteoporosis	8.67e-05	0.00129	CcSEcCtD
Testosterone Propionate—Discomfort—Zoledronate—osteoporosis	8.67e-05	0.00129	CcSEcCtD
Testosterone Propionate—Asthenia—Alendronate—osteoporosis	8.66e-05	0.00129	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP19A1—osteoporosis	8.66e-05	0.0064	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Ibandronate—osteoporosis	8.66e-05	0.00129	CcSEcCtD
Testosterone Propionate—Dyspnoea—Risedronate—osteoporosis	8.64e-05	0.00128	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	8.58e-05	0.00127	CcSEcCtD
Testosterone Propionate—Fatigue—Ethinyl Estradiol—osteoporosis	8.57e-05	0.00127	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP19A1—osteoporosis	8.54e-05	0.00631	CbGpPWpGaD
Testosterone Propionate—Pruritus—Alendronate—osteoporosis	8.54e-05	0.00127	CcSEcCtD
Testosterone Propionate—Levonorgestrel—CYP19A1—osteoporosis	8.51e-05	0.0334	CrCbGaD
Testosterone Propionate—Confusional state—Zoledronate—osteoporosis	8.48e-05	0.00126	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Calcitriol—osteoporosis	8.48e-05	0.00126	CcSEcCtD
Testosterone Propionate—Arthralgia—Conjugated Estrogens—osteoporosis	8.45e-05	0.00125	CcSEcCtD
Testosterone Propionate—Myalgia—Conjugated Estrogens—osteoporosis	8.45e-05	0.00125	CcSEcCtD
Testosterone Propionate—Asthenia—Ibandronate—osteoporosis	8.43e-05	0.00125	CcSEcCtD
Testosterone Propionate—Anxiety—Conjugated Estrogens—osteoporosis	8.42e-05	0.00125	CcSEcCtD
Testosterone Propionate—Nausea—Etidronic acid—osteoporosis	8.42e-05	0.00125	CcSEcCtD
Testosterone Propionate—Oedema—Zoledronate—osteoporosis	8.41e-05	0.00125	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Zoledronate—osteoporosis	8.41e-05	0.00125	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	8.39e-05	0.00125	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Pamidronate—osteoporosis	8.39e-05	0.00125	CcSEcCtD
Testosterone Propionate—Diarrhoea—Estropipate—osteoporosis	8.39e-05	0.00125	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Risedronate—osteoporosis	8.36e-05	0.00124	CcSEcCtD
Testosterone Propionate—Fatigue—Risedronate—osteoporosis	8.35e-05	0.00124	CcSEcCtD
Testosterone Propionate—Insomnia—Pamidronate—osteoporosis	8.33e-05	0.00124	CcSEcCtD
Testosterone Propionate—Pruritus—Ibandronate—osteoporosis	8.32e-05	0.00123	CcSEcCtD
Testosterone Propionate—Pain—Risedronate—osteoporosis	8.28e-05	0.00123	CcSEcCtD
Testosterone Propionate—Angiopathy—Estradiol—osteoporosis	8.28e-05	0.00123	CcSEcCtD
Testosterone Propionate—Paraesthesia—Pamidronate—osteoporosis	8.27e-05	0.00123	CcSEcCtD
Testosterone Propionate—Diarrhoea—Alendronate—osteoporosis	8.26e-05	0.00123	CcSEcCtD
Testosterone Propionate—Asthenia—Calcitriol—osteoporosis	8.26e-05	0.00123	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Zoledronate—osteoporosis	8.25e-05	0.00122	CcSEcCtD
Testosterone Propionate—Immune system disorder—Estradiol—osteoporosis	8.24e-05	0.00122	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Estradiol—osteoporosis	8.22e-05	0.00122	CcSEcCtD
Testosterone Propionate—Dyspnoea—Pamidronate—osteoporosis	8.21e-05	0.00122	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	8.19e-05	0.00122	CcSEcCtD
Testosterone Propionate—Skin disorder—Zoledronate—osteoporosis	8.17e-05	0.00121	CcSEcCtD
Testosterone Propionate—Pruritus—Calcitriol—osteoporosis	8.14e-05	0.00121	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.13e-05	0.006	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	8.12e-05	0.00121	CcSEcCtD
Testosterone Propionate—Diarrhoea—Raloxifene—osteoporosis	8.12e-05	0.00121	CcSEcCtD
Testosterone Propionate—Dizziness—Estropipate—osteoporosis	8.11e-05	0.0012	CcSEcCtD
Testosterone Propionate—Oedema—Conjugated Estrogens—osteoporosis	8.1e-05	0.0012	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	8.1e-05	0.0012	CcSEcCtD
Testosterone Propionate—Alopecia—Estradiol—osteoporosis	8.06e-05	0.0012	CcSEcCtD
Testosterone Propionate—Diarrhoea—Ibandronate—osteoporosis	8.04e-05	0.00119	CcSEcCtD
Testosterone Propionate—Mental disorder—Estradiol—osteoporosis	7.99e-05	0.00119	CcSEcCtD
Testosterone Propionate—Dizziness—Alendronate—osteoporosis	7.98e-05	0.00119	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Pamidronate—osteoporosis	7.95e-05	0.00118	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Conjugated Estrogens—osteoporosis	7.94e-05	0.00118	CcSEcCtD
Testosterone Propionate—Malnutrition—Estradiol—osteoporosis	7.94e-05	0.00118	CcSEcCtD
Testosterone Propionate—Fatigue—Pamidronate—osteoporosis	7.94e-05	0.00118	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Risedronate—osteoporosis	7.92e-05	0.00118	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.92e-05	0.00585	CbGpPWpGaD
Testosterone Propionate—Urticaria—Ethinyl Estradiol—osteoporosis	7.89e-05	0.00117	CcSEcCtD
Testosterone Propionate—Pain—Pamidronate—osteoporosis	7.88e-05	0.00117	CcSEcCtD
Testosterone Propionate—Diarrhoea—Calcitriol—osteoporosis	7.87e-05	0.00117	CcSEcCtD
Testosterone Propionate—Skin disorder—Conjugated Estrogens—osteoporosis	7.87e-05	0.00117	CcSEcCtD
Testosterone Propionate—Abdominal pain—Ethinyl Estradiol—osteoporosis	7.85e-05	0.00117	CcSEcCtD
Testosterone Propionate—Dizziness—Raloxifene—osteoporosis	7.85e-05	0.00117	CcSEcCtD
Testosterone Propionate—Levonorgestrel—ESR1—osteoporosis	7.83e-05	0.0307	CrCbGaD
Testosterone Propionate—Vomiting—Estropipate—osteoporosis	7.79e-05	0.00116	CcSEcCtD
Testosterone Propionate—Dizziness—Ibandronate—osteoporosis	7.77e-05	0.00115	CcSEcCtD
Testosterone Propionate—Danazol—CYP19A1—osteoporosis	7.75e-05	0.0304	CrCbGaD
Testosterone Propionate—Rash—Estropipate—osteoporosis	7.73e-05	0.00115	CcSEcCtD
Testosterone Propionate—Dermatitis—Estropipate—osteoporosis	7.72e-05	0.00115	CcSEcCtD
Testosterone Propionate—Urticaria—Risedronate—osteoporosis	7.7e-05	0.00114	CcSEcCtD
Testosterone Propionate—Headache—Estropipate—osteoporosis	7.68e-05	0.00114	CcSEcCtD
Testosterone Propionate—Vomiting—Alendronate—osteoporosis	7.68e-05	0.00114	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Zoledronate—osteoporosis	7.66e-05	0.00114	CcSEcCtD
Testosterone Propionate—Abdominal pain—Risedronate—osteoporosis	7.66e-05	0.00114	CcSEcCtD
Testosterone Propionate—Rash—Alendronate—osteoporosis	7.61e-05	0.00113	CcSEcCtD
Testosterone Propionate—Insomnia—Zoledronate—osteoporosis	7.61e-05	0.00113	CcSEcCtD
Testosterone Propionate—Dermatitis—Alendronate—osteoporosis	7.61e-05	0.00113	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Pamidronate—osteoporosis	7.59e-05	0.00113	CcSEcCtD
Testosterone Propionate—Headache—Alendronate—osteoporosis	7.56e-05	0.00112	CcSEcCtD
Testosterone Propionate—Paraesthesia—Zoledronate—osteoporosis	7.55e-05	0.00112	CcSEcCtD
Testosterone Propionate—Vomiting—Raloxifene—osteoporosis	7.55e-05	0.00112	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Pamidronate—osteoporosis	7.53e-05	0.00112	CcSEcCtD
Testosterone Propionate—Dyspnoea—Zoledronate—osteoporosis	7.5e-05	0.00111	CcSEcCtD
Testosterone Propionate—Rash—Raloxifene—osteoporosis	7.49e-05	0.00111	CcSEcCtD
Testosterone Propionate—Dermatitis—Raloxifene—osteoporosis	7.48e-05	0.00111	CcSEcCtD
Testosterone Propionate—Vomiting—Ibandronate—osteoporosis	7.47e-05	0.00111	CcSEcCtD
Testosterone Propionate—Fluoxymesterone—ESR1—osteoporosis	7.47e-05	0.0293	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	7.44e-05	0.00549	CbGpPWpGaD
Testosterone Propionate—Headache—Raloxifene—osteoporosis	7.44e-05	0.0011	CcSEcCtD
Testosterone Propionate—Rash—Ibandronate—osteoporosis	7.41e-05	0.0011	CcSEcCtD
Testosterone Propionate—Dermatitis—Ibandronate—osteoporosis	7.4e-05	0.0011	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	7.38e-05	0.0011	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Estradiol—osteoporosis	7.37e-05	0.00109	CcSEcCtD
Testosterone Propionate—Headache—Ibandronate—osteoporosis	7.36e-05	0.00109	CcSEcCtD
Testosterone Propionate—Insomnia—Conjugated Estrogens—osteoporosis	7.33e-05	0.00109	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	7.32e-05	0.00109	CcSEcCtD
Testosterone Propionate—Vomiting—Calcitriol—osteoporosis	7.32e-05	0.00109	CcSEcCtD
Testosterone Propionate—Nausea—Estropipate—osteoporosis	7.28e-05	0.00108	CcSEcCtD
Testosterone Propionate—Abdominal pain—Pamidronate—osteoporosis	7.28e-05	0.00108	CcSEcCtD
Testosterone Propionate—Paraesthesia—Conjugated Estrogens—osteoporosis	7.27e-05	0.00108	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—ESR2—osteoporosis	7.26e-05	0.00536	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Zoledronate—osteoporosis	7.26e-05	0.00108	CcSEcCtD
Testosterone Propionate—Rash—Calcitriol—osteoporosis	7.26e-05	0.00108	CcSEcCtD
Testosterone Propionate—Fatigue—Zoledronate—osteoporosis	7.25e-05	0.00108	CcSEcCtD
Testosterone Propionate—Dermatitis—Calcitriol—osteoporosis	7.25e-05	0.00108	CcSEcCtD
Testosterone Propionate—Dyspnoea—Conjugated Estrogens—osteoporosis	7.22e-05	0.00107	CcSEcCtD
Testosterone Propionate—Headache—Calcitriol—osteoporosis	7.21e-05	0.00107	CcSEcCtD
Testosterone Propionate—Pain—Zoledronate—osteoporosis	7.19e-05	0.00107	CcSEcCtD
Testosterone Propionate—Nausea—Alendronate—osteoporosis	7.17e-05	0.00106	CcSEcCtD
Testosterone Propionate—Malaise—Estradiol—osteoporosis	7.16e-05	0.00106	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Risedronate—osteoporosis	7.14e-05	0.00106	CcSEcCtD
Testosterone Propionate—Danazol—ESR1—osteoporosis	7.14e-05	0.028	CrCbGaD
Testosterone Propionate—Asthenia—Ethinyl Estradiol—osteoporosis	7.13e-05	0.00106	CcSEcCtD
Testosterone Propionate—Nausea—Raloxifene—osteoporosis	7.05e-05	0.00105	CcSEcCtD
Testosterone Propionate—Pruritus—Ethinyl Estradiol—osteoporosis	7.03e-05	0.00104	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	6.99e-05	0.00104	CcSEcCtD
Testosterone Propionate—Fatigue—Conjugated Estrogens—osteoporosis	6.98e-05	0.00104	CcSEcCtD
Testosterone Propionate—Nausea—Ibandronate—osteoporosis	6.98e-05	0.00104	CcSEcCtD
Testosterone Propionate—Asthenia—Risedronate—osteoporosis	6.95e-05	0.00103	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	6.94e-05	0.00513	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Zoledronate—osteoporosis	6.93e-05	0.00103	CcSEcCtD
Testosterone Propionate—Pain—Conjugated Estrogens—osteoporosis	6.93e-05	0.00103	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Zoledronate—osteoporosis	6.88e-05	0.00102	CcSEcCtD
Testosterone Propionate—Hypertension—Estradiol—osteoporosis	6.86e-05	0.00102	CcSEcCtD
Testosterone Propionate—Pruritus—Risedronate—osteoporosis	6.85e-05	0.00102	CcSEcCtD
Testosterone Propionate—Nausea—Calcitriol—osteoporosis	6.84e-05	0.00101	CcSEcCtD
Testosterone Propionate—Diarrhoea—Ethinyl Estradiol—osteoporosis	6.8e-05	0.00101	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Pamidronate—osteoporosis	6.78e-05	0.00101	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	6.77e-05	0.005	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Estradiol—osteoporosis	6.76e-05	0.001	CcSEcCtD
Testosterone Propionate—Myalgia—Estradiol—osteoporosis	6.76e-05	0.001	CcSEcCtD
Testosterone Propionate—Anxiety—Estradiol—osteoporosis	6.74e-05	0.001	CcSEcCtD
Testosterone Propionate—Hydrocortisone—SHBG—osteoporosis	6.72e-05	0.0263	CrCbGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	6.72e-05	0.000997	CcSEcCtD
Testosterone Propionate—Urticaria—Zoledronate—osteoporosis	6.68e-05	0.000992	CcSEcCtD
Testosterone Propionate—Discomfort—Estradiol—osteoporosis	6.68e-05	0.000992	CcSEcCtD
Testosterone Propionate—Abdominal pain—Zoledronate—osteoporosis	6.65e-05	0.000987	CcSEcCtD
Testosterone Propionate—Diarrhoea—Risedronate—osteoporosis	6.63e-05	0.000984	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	6.62e-05	0.000983	CcSEcCtD
Testosterone Propionate—Asthenia—Pamidronate—osteoporosis	6.61e-05	0.000981	CcSEcCtD
Testosterone Propionate—Dizziness—Ethinyl Estradiol—osteoporosis	6.57e-05	0.000975	CcSEcCtD
Testosterone Propionate—Methyltestosterone—CYP19A1—osteoporosis	6.55e-05	0.0257	CrCbGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.55e-05	0.00484	CbGpPWpGaD
Testosterone Propionate—Confusional state—Estradiol—osteoporosis	6.54e-05	0.00097	CcSEcCtD
Testosterone Propionate—Pruritus—Pamidronate—osteoporosis	6.52e-05	0.000967	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Estradiol—osteoporosis	6.48e-05	0.000962	CcSEcCtD
Testosterone Propionate—Oedema—Estradiol—osteoporosis	6.48e-05	0.000962	CcSEcCtD
Testosterone Propionate—Urticaria—Conjugated Estrogens—osteoporosis	6.43e-05	0.000955	CcSEcCtD
Testosterone Propionate—Dizziness—Risedronate—osteoporosis	6.41e-05	0.000951	CcSEcCtD
Testosterone Propionate—Medroxyprogesterone Acetate—ESR1—osteoporosis	6.41e-05	0.0251	CrCbGaD
Testosterone Propionate—Abdominal pain—Conjugated Estrogens—osteoporosis	6.4e-05	0.000951	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Estradiol—osteoporosis	6.36e-05	0.000944	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.33e-05	0.00468	CbGpPWpGaD
Testosterone Propionate—Vomiting—Ethinyl Estradiol—osteoporosis	6.32e-05	0.000938	CcSEcCtD
Testosterone Propionate—Diarrhoea—Pamidronate—osteoporosis	6.3e-05	0.000935	CcSEcCtD
Testosterone Propionate—Skin disorder—Estradiol—osteoporosis	6.3e-05	0.000935	CcSEcCtD
Testosterone Propionate—Rash—Ethinyl Estradiol—osteoporosis	6.26e-05	0.00093	CcSEcCtD
Testosterone Propionate—Dermatitis—Ethinyl Estradiol—osteoporosis	6.26e-05	0.000929	CcSEcCtD
Testosterone Propionate—Headache—Ethinyl Estradiol—osteoporosis	6.22e-05	0.000924	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Zoledronate—osteoporosis	6.2e-05	0.00092	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	6.18e-05	0.00456	CbGpPWpGaD
Testosterone Propionate—Vomiting—Risedronate—osteoporosis	6.16e-05	0.000914	CcSEcCtD
Testosterone Propionate—Rash—Risedronate—osteoporosis	6.11e-05	0.000907	CcSEcCtD
Testosterone Propionate—Dermatitis—Risedronate—osteoporosis	6.1e-05	0.000906	CcSEcCtD
Testosterone Propionate—Dizziness—Pamidronate—osteoporosis	6.09e-05	0.000904	CcSEcCtD
Testosterone Propionate—Headache—Risedronate—osteoporosis	6.07e-05	0.000901	CcSEcCtD
Testosterone Propionate—Asthenia—Zoledronate—osteoporosis	6.04e-05	0.000896	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Conjugated Estrogens—osteoporosis	5.97e-05	0.000886	CcSEcCtD
Testosterone Propionate—Pruritus—Zoledronate—osteoporosis	5.95e-05	0.000883	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Estradiol—osteoporosis	5.91e-05	0.000877	CcSEcCtD
Testosterone Propionate—Nausea—Ethinyl Estradiol—osteoporosis	5.9e-05	0.000876	CcSEcCtD
Testosterone Propionate—Insomnia—Estradiol—osteoporosis	5.86e-05	0.00087	CcSEcCtD
Testosterone Propionate—Vomiting—Pamidronate—osteoporosis	5.86e-05	0.000869	CcSEcCtD
Testosterone Propionate—Paraesthesia—Estradiol—osteoporosis	5.82e-05	0.000864	CcSEcCtD
Testosterone Propionate—Asthenia—Conjugated Estrogens—osteoporosis	5.81e-05	0.000863	CcSEcCtD
Testosterone Propionate—Rash—Pamidronate—osteoporosis	5.81e-05	0.000862	CcSEcCtD
Testosterone Propionate—Dermatitis—Pamidronate—osteoporosis	5.8e-05	0.000861	CcSEcCtD
Testosterone Propionate—Dyspnoea—Estradiol—osteoporosis	5.78e-05	0.000858	CcSEcCtD
Testosterone Propionate—Headache—Pamidronate—osteoporosis	5.77e-05	0.000856	CcSEcCtD
Testosterone Propionate—Diarrhoea—Zoledronate—osteoporosis	5.76e-05	0.000854	CcSEcCtD
Testosterone Propionate—Nausea—Risedronate—osteoporosis	5.75e-05	0.000854	CcSEcCtD
Testosterone Propionate—Pruritus—Conjugated Estrogens—osteoporosis	5.73e-05	0.000851	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Estradiol—osteoporosis	5.6e-05	0.000831	CcSEcCtD
Testosterone Propionate—Fatigue—Estradiol—osteoporosis	5.59e-05	0.00083	CcSEcCtD
Testosterone Propionate—Dizziness—Zoledronate—osteoporosis	5.56e-05	0.000826	CcSEcCtD
Testosterone Propionate—Pain—Estradiol—osteoporosis	5.54e-05	0.000823	CcSEcCtD
Testosterone Propionate—Diarrhoea—Conjugated Estrogens—osteoporosis	5.54e-05	0.000823	CcSEcCtD
Testosterone Propionate—Progesterone—SHBG—osteoporosis	5.48e-05	0.0215	CrCbGaD
Testosterone Propionate—Nausea—Pamidronate—osteoporosis	5.47e-05	0.000812	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—POMC—osteoporosis	5.44e-05	0.00401	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP19A1—osteoporosis	5.42e-05	0.004	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	5.39e-05	0.00398	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.38e-05	0.00398	CbGpPWpGaD
Testosterone Propionate—Dizziness—Conjugated Estrogens—osteoporosis	5.36e-05	0.000795	CcSEcCtD
Testosterone Propionate—Vomiting—Zoledronate—osteoporosis	5.35e-05	0.000794	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP19A1—osteoporosis	5.34e-05	0.00395	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Estradiol—osteoporosis	5.34e-05	0.000793	CcSEcCtD
Testosterone Propionate—Rash—Zoledronate—osteoporosis	5.3e-05	0.000787	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Estradiol—osteoporosis	5.3e-05	0.000787	CcSEcCtD
Testosterone Propionate—Dermatitis—Zoledronate—osteoporosis	5.3e-05	0.000787	CcSEcCtD
Testosterone Propionate—Headache—Zoledronate—osteoporosis	5.27e-05	0.000782	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—POMC—osteoporosis	5.21e-05	0.00384	CbGpPWpGaD
Testosterone Propionate—Testosterone—SHBG—osteoporosis	5.18e-05	0.0203	CrCbGaD
Testosterone Propionate—Vomiting—Conjugated Estrogens—osteoporosis	5.15e-05	0.000765	CcSEcCtD
Testosterone Propionate—Urticaria—Estradiol—osteoporosis	5.15e-05	0.000764	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—FDPS—osteoporosis	5.13e-05	0.00379	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PKM—osteoporosis	5.13e-05	0.00379	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Estradiol—osteoporosis	5.12e-05	0.000761	CcSEcCtD
Testosterone Propionate—Rash—Conjugated Estrogens—osteoporosis	5.11e-05	0.000758	CcSEcCtD
Testosterone Propionate—Dermatitis—Conjugated Estrogens—osteoporosis	5.1e-05	0.000757	CcSEcCtD
Testosterone Propionate—Headache—Conjugated Estrogens—osteoporosis	5.07e-05	0.000753	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—AGER—osteoporosis	5.07e-05	0.00374	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	5.04e-05	0.00372	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—ADCY5—osteoporosis	5.02e-05	0.00371	CbGpPWpGaD
Testosterone Propionate—Nausea—Zoledronate—osteoporosis	5e-05	0.000742	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—FDPS—osteoporosis	4.91e-05	0.00363	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PKM—osteoporosis	4.91e-05	0.00363	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GPD2—osteoporosis	4.86e-05	0.00359	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PGLS—osteoporosis	4.86e-05	0.00359	CbGpPWpGaD
Testosterone Propionate—Nausea—Conjugated Estrogens—osteoporosis	4.81e-05	0.000714	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Estradiol—osteoporosis	4.78e-05	0.000709	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—PGLS—osteoporosis	4.65e-05	0.00344	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GPD2—osteoporosis	4.65e-05	0.00344	CbGpPWpGaD
Testosterone Propionate—Asthenia—Estradiol—osteoporosis	4.65e-05	0.00069	CcSEcCtD
Testosterone Propionate—Pruritus—Estradiol—osteoporosis	4.59e-05	0.000681	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ESR1—osteoporosis	4.52e-05	0.00334	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ATIC—osteoporosis	4.45e-05	0.00328	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PNP—osteoporosis	4.45e-05	0.00328	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Estradiol—osteoporosis	4.44e-05	0.000658	CcSEcCtD
Testosterone Propionate—Dizziness—Estradiol—osteoporosis	4.29e-05	0.000636	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—PNP—osteoporosis	4.26e-05	0.00314	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ATIC—osteoporosis	4.26e-05	0.00314	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—IRS1—osteoporosis	4.22e-05	0.00312	CbGpPWpGaD
Testosterone Propionate—Vomiting—Estradiol—osteoporosis	4.12e-05	0.000612	CcSEcCtD
Testosterone Propionate—Rash—Estradiol—osteoporosis	4.09e-05	0.000607	CcSEcCtD
Testosterone Propionate—Dermatitis—Estradiol—osteoporosis	4.08e-05	0.000606	CcSEcCtD
Testosterone Propionate—Headache—Estradiol—osteoporosis	4.06e-05	0.000603	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	3.91e-05	0.00289	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	3.87e-05	0.00286	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6R—osteoporosis	3.87e-05	0.00285	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—U2AF1—osteoporosis	3.85e-05	0.00285	CbGpPWpGaD
Testosterone Propionate—Nausea—Estradiol—osteoporosis	3.85e-05	0.000572	CcSEcCtD
Testosterone Propionate—Testosterone—CYP19A1—osteoporosis	3.8e-05	0.0149	CrCbGaD
Testosterone Propionate—COMT—Metabolism—OXCT1—osteoporosis	3.78e-05	0.00279	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CA2—osteoporosis	3.78e-05	0.00279	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.75e-05	0.00277	CbGpPWpGaD
Testosterone Propionate—Progesterone—ESR1—osteoporosis	3.7e-05	0.0145	CrCbGaD
Testosterone Propionate—COMT—Metabolism—MGLL—osteoporosis	3.68e-05	0.00272	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CA2—osteoporosis	3.62e-05	0.00267	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—OXCT1—osteoporosis	3.62e-05	0.00267	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MGLL—osteoporosis	3.53e-05	0.0026	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.33e-05	0.00246	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—POMC—osteoporosis	3.26e-05	0.0024	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.24e-05	0.00239	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—IDH2—osteoporosis	3.13e-05	0.00231	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PKM—osteoporosis	3.07e-05	0.00227	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—FDPS—osteoporosis	3.07e-05	0.00227	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR2—osteoporosis	3.07e-05	0.00227	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—IDH2—osteoporosis	3e-05	0.00221	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP27A1—osteoporosis	2.94e-05	0.00217	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	2.94e-05	0.00217	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GPD2—osteoporosis	2.91e-05	0.00215	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PGLS—osteoporosis	2.91e-05	0.00215	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPL24—osteoporosis	2.87e-05	0.00212	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ACP5—osteoporosis	2.86e-05	0.00212	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP27A1—osteoporosis	2.82e-05	0.00208	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ACP5—osteoporosis	2.74e-05	0.00203	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.71e-05	0.002	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ATIC—osteoporosis	2.66e-05	0.00197	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TPI1—osteoporosis	2.66e-05	0.00197	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PNP—osteoporosis	2.66e-05	0.00197	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TPI1—osteoporosis	2.55e-05	0.00188	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—P4HB—osteoporosis	2.5e-05	0.00185	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GAPDH—osteoporosis	2.46e-05	0.00181	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—VDR—osteoporosis	2.44e-05	0.0018	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—P4HB—osteoporosis	2.4e-05	0.00177	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—RAP1A—osteoporosis	2.39e-05	0.00177	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GAPDH—osteoporosis	2.35e-05	0.00174	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	2.35e-05	0.00174	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—RAP1A—osteoporosis	2.29e-05	0.00169	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—OXCT1—osteoporosis	2.26e-05	0.00167	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CA2—osteoporosis	2.26e-05	0.00167	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MGLL—osteoporosis	2.21e-05	0.00163	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB1—osteoporosis	2.14e-05	0.00158	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	2.13e-05	0.00158	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2e-05	0.00148	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.95e-05	0.00144	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.94e-05	0.00144	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ENO1—osteoporosis	1.94e-05	0.00143	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PSMA2—osteoporosis	1.91e-05	0.00141	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PSMA5—osteoporosis	1.91e-05	0.00141	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—IDH2—osteoporosis	1.88e-05	0.00139	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR1—osteoporosis	1.86e-05	0.00137	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ENO1—osteoporosis	1.85e-05	0.00137	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PSMA2—osteoporosis	1.83e-05	0.00135	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PSMA5—osteoporosis	1.83e-05	0.00135	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.82e-05	0.00134	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP27A1—osteoporosis	1.76e-05	0.0013	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	1.72e-05	0.00127	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ACP5—osteoporosis	1.72e-05	0.00127	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PSMA2—osteoporosis	1.65e-05	0.00122	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PSMA5—osteoporosis	1.65e-05	0.00122	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TPI1—osteoporosis	1.6e-05	0.00118	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP19A1—osteoporosis	1.55e-05	0.00114	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—P4HB—osteoporosis	1.5e-05	0.00111	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP19A1—osteoporosis	1.48e-05	0.00109	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR2—osteoporosis	1.48e-05	0.00109	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GAPDH—osteoporosis	1.47e-05	0.00109	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—RAP1A—osteoporosis	1.43e-05	0.00106	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ADCY5—osteoporosis	1.26e-05	0.000933	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GPX1—osteoporosis	1.26e-05	0.00093	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ADCY5—osteoporosis	1.21e-05	0.000894	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GPX1—osteoporosis	1.21e-05	0.000891	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—VDR—osteoporosis	1.17e-05	0.000866	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MTHFR—osteoporosis	1.16e-05	0.000858	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ENO1—osteoporosis	1.16e-05	0.000856	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PSMA5—osteoporosis	1.14e-05	0.000843	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PSMA2—osteoporosis	1.14e-05	0.000843	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MTHFR—osteoporosis	1.11e-05	0.000822	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—osteoporosis	9.68e-06	0.000715	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—POMC—osteoporosis	9.3e-06	0.000686	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP19A1—osteoporosis	9.27e-06	0.000684	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR1—osteoporosis	8.96e-06	0.000662	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—POMC—osteoporosis	8.9e-06	0.000657	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ADCY5—osteoporosis	7.57e-06	0.000559	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GPX1—osteoporosis	7.55e-06	0.000557	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTHFR—osteoporosis	6.96e-06	0.000514	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—POMC—osteoporosis	5.57e-06	0.000411	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—osteoporosis	4.66e-06	0.000344	CbGpPWpGaD
